Edwards Lifesciences (EW) is a health care equipment company in the Health Care sector. Listed on the NASDAQ, Edwards Lifesciences is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $85.98.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $85.98 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 2.60% |
| Risk / Std Dev (Annualized) | 32.63% |
| Sharpe Ratio (rf=4.5%) | -0.06 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Health Care Equipment
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 2.60% with an annualized volatility of 32.63%. The Sharpe ratio of -0.06 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 49.51B |
| Enterprise Value | 46.54B |
| Trailing P/E | 46.48 |
| Forward P/E | 25.53 |
| Price to Book | 4.8 |
| Price to Sales | 7.85 |
| EV/Revenue | 7.38 |
| EV/EBITDA | 24.45 |
| Profitability | | | Profit Margin | 17.39% | | Operating Margin | 31.22% | | ROE | 10.46% | | ROA | 8.27% |
| Growth | | | Revenue Growth | 16.7% | | Earnings Growth | 8.2% |
| Financial Health | | | Total Revenue | 6.3B | | Total Debt | 0.7B | | Total Cash | 3.67B | | Free Cash Flow | 0.9B | | Operating Cash Flow | 1.36B |
| Price & Technical | | | 52W High | $89.48$ | | 52W Low | $72.3$ | | 50-Day Avg | $82.46$ | | 200-Day Avg | $81.78$ | | Beta | 0.87 | | Shares Outstanding | 0.58B | | Float Shares | 0.57B | | Insider Holdings | 0.18% | | Institutional Holdings | 94.08% | | Short Ratio | 2.48 | | Short % of Float | 2.4% |
| Analyst Targets | | | Target High | $110.0$ | | Target Low | $84.0$ | | Target Mean | $96.92$ | | Target Median | $100.0$ | | # of Analysts | 26 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.